Klaus P Hoeflich - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Klaus P Hoeflich

Showing results (61-70 of 61) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 61 results.

Cancer Discovery|October 3, 2019

First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular CarcinomaRichard D Kim, Debashis Sarker, Tim Meyer, et al.

Pageof 7

Search research articles

Showing results (61-70 of 61) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 61 results.

Cancer Discovery|October 3, 2019

First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular CarcinomaRichard D Kim, Debashis Sarker, Tim Meyer, et al.

Pageof 7